New Investor Discloses 10.9% Stake in Distressed Aditxt
ADTX has more than doubled off its 52-week low of $0.004 on elevated volume (13× avg).
Summary
Takeover Time 2026 LLC has disclosed a 10.9% stake in Aditxt, acquiring 3.42 million shares on June 12. This investment follows a period of severe financial distress for Aditxt, including a Nasdaq delisting notice, a recent 1-for-27 reverse stock split, and ongoing going concern doubts. While the investor states the stake is for passive "investment purposes," a new significant shareholder could signal a speculative interest in the highly challenged company.
At the time of this announcement, ADTX was trading at $0.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.2K. The 52-week trading range was $0.00 to $53,450.61. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.